Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767832 · ClinicalTrials.gov registry record
Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 60
- Enrollment target
NCT00767832: Completed study, sponsored by Stanford University.
NCT00767832 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767832 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00767832
The ClinicalTrials.gov registry entry for NCT00767832 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00767832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00767832 about?
NCT00767832 is a clinical study titled "Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.". The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and relate...
What is the current status of trial NCT00767832?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-08. Estimated completion is 2009-06.
Who is sponsoring clinical trial NCT00767832?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.